| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | D-ribulose-phosphate 3-epimerase activity | 4.97e-06 | 2 | 45 | 2 | GO:0004750 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.59e-06 | 441 | 45 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.63e-06 | 614 | 45 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | racemase and epimerase activity, acting on carbohydrates and derivatives | 2.70e-04 | 11 | 45 | 2 | GO:0016857 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.99e-04 | 775 | 45 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 5.09e-04 | 839 | 45 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 5.13e-04 | 840 | 45 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.13e-04 | 840 | 45 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | racemase and epimerase activity | 7.43e-04 | 18 | 45 | 2 | GO:0016854 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.18e-03 | 206 | 45 | 4 | GO:0140030 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.23e-03 | 739 | 45 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.40e-03 | 98 | 45 | 3 | GO:0031491 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.93e-03 | 127 | 45 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | histone binding | 2.95e-03 | 265 | 45 | 4 | GO:0042393 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.15e-03 | 37 | 45 | 2 | GO:0140658 | |
| Domain | Ribul_P_3_epim | 5.42e-06 | 2 | 44 | 2 | PF00834 | |
| Domain | RIBUL_P_3_EPIMER_1 | 5.42e-06 | 2 | 44 | 2 | PS01085 | |
| Domain | Ribul_P_3_epim | 5.42e-06 | 2 | 44 | 2 | IPR026019 | |
| Domain | Ribul_P_3_epim-like | 5.42e-06 | 2 | 44 | 2 | IPR000056 | |
| Domain | CHDCT2 | 1.62e-05 | 3 | 44 | 2 | PF08074 | |
| Domain | CHDNT | 1.62e-05 | 3 | 44 | 2 | PF08073 | |
| Domain | DUF1086 | 1.62e-05 | 3 | 44 | 2 | IPR009462 | |
| Domain | DUF1087 | 1.62e-05 | 3 | 44 | 2 | IPR009463 | |
| Domain | CHD_N | 1.62e-05 | 3 | 44 | 2 | IPR012958 | |
| Domain | CHD_C2 | 1.62e-05 | 3 | 44 | 2 | IPR012957 | |
| Domain | DUF1087 | 1.62e-05 | 3 | 44 | 2 | PF06465 | |
| Domain | DUF1086 | 1.62e-05 | 3 | 44 | 2 | PF06461 | |
| Domain | DUF1087 | 1.62e-05 | 3 | 44 | 2 | SM01147 | |
| Domain | DUF1086 | 1.62e-05 | 3 | 44 | 2 | SM01146 | |
| Domain | RibuloseP-bd_barrel | 1.62e-05 | 3 | 44 | 2 | IPR011060 | |
| Domain | AAA+_ATPase | 2.17e-05 | 144 | 44 | 5 | IPR003593 | |
| Domain | AAA | 2.17e-05 | 144 | 44 | 5 | SM00382 | |
| Domain | - | 3.09e-04 | 746 | 44 | 8 | 3.40.50.300 | |
| Domain | CH | 4.81e-04 | 65 | 44 | 3 | SM00033 | |
| Domain | CH | 5.98e-04 | 70 | 44 | 3 | PF00307 | |
| Domain | - | 6.23e-04 | 71 | 44 | 3 | 1.10.418.10 | |
| Domain | CH | 6.76e-04 | 73 | 44 | 3 | PS50021 | |
| Domain | P-loop_NTPase | 7.23e-04 | 848 | 44 | 8 | IPR027417 | |
| Domain | CH-domain | 7.32e-04 | 75 | 44 | 3 | IPR001715 | |
| Domain | DAPIN | 1.22e-03 | 22 | 44 | 2 | PS50824 | |
| Domain | PYRIN | 1.22e-03 | 22 | 44 | 2 | PF02758 | |
| Domain | DAPIN | 1.22e-03 | 22 | 44 | 2 | IPR004020 | |
| Domain | PYRIN | 1.22e-03 | 22 | 44 | 2 | SM01289 | |
| Domain | Actinin_actin-bd_CS | 1.33e-03 | 23 | 44 | 2 | IPR001589 | |
| Domain | NACHT | 1.33e-03 | 23 | 44 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 1.33e-03 | 23 | 44 | 2 | IPR007111 | |
| Domain | Spectrin | 1.33e-03 | 23 | 44 | 2 | PF00435 | |
| Domain | ACTININ_2 | 1.33e-03 | 23 | 44 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.33e-03 | 23 | 44 | 2 | PS00019 | |
| Domain | Chromo_domain | 1.45e-03 | 24 | 44 | 2 | IPR023780 | |
| Domain | Chromo | 1.70e-03 | 26 | 44 | 2 | PF00385 | |
| Domain | CHROMO_1 | 1.97e-03 | 28 | 44 | 2 | PS00598 | |
| Domain | CHROMO_2 | 1.97e-03 | 28 | 44 | 2 | PS50013 | |
| Domain | ATPase_AAA_CS | 2.11e-03 | 29 | 44 | 2 | IPR003960 | |
| Domain | Spectrin_repeat | 2.11e-03 | 29 | 44 | 2 | IPR002017 | |
| Domain | SNF2_N | 2.57e-03 | 32 | 44 | 2 | IPR000330 | |
| Domain | Spectrin/alpha-actinin | 2.57e-03 | 32 | 44 | 2 | IPR018159 | |
| Domain | Chromodomain-like | 2.57e-03 | 32 | 44 | 2 | IPR016197 | |
| Domain | SNF2_N | 2.57e-03 | 32 | 44 | 2 | PF00176 | |
| Domain | SPEC | 2.57e-03 | 32 | 44 | 2 | SM00150 | |
| Domain | Chromo/shadow_dom | 2.73e-03 | 33 | 44 | 2 | IPR000953 | |
| Domain | CHROMO | 2.73e-03 | 33 | 44 | 2 | SM00298 | |
| Domain | AAA | 2.90e-03 | 34 | 44 | 2 | PS00674 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.07e-03 | 35 | 44 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 3.61e-03 | 38 | 44 | 2 | PS00690 | |
| Domain | - | 4.40e-03 | 42 | 44 | 2 | 3.20.20.70 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.44e-06 | 608 | 47 | 8 | 36089195 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 2.37e-06 | 69 | 47 | 4 | 28481362 | |
| Pubmed | MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses. | 5.36e-06 | 3 | 47 | 2 | 30842214 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 7396409 | ||
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 1.60e-05 | 36 | 47 | 3 | 29089422 | |
| Pubmed | Proteomic analysis of mouse thymoma EL4 cells treated with bis(tri-n-butyltin)oxide (TBTO). | 1.78e-05 | 5 | 47 | 2 | 19552622 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 5360673 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 12387869 | ||
| Pubmed | Interaction of Ras with p110γ is required for thymic β-selection in the mouse. | 2.67e-05 | 6 | 47 | 2 | 21930962 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 18191593 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 23499492 | ||
| Pubmed | HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins. | 4.98e-05 | 8 | 47 | 2 | 15875659 | |
| Pubmed | Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design. | 4.98e-05 | 8 | 47 | 2 | 16075307 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 12019269 | ||
| Pubmed | 5.96e-05 | 506 | 47 | 6 | 30890647 | ||
| Pubmed | Characterization of cDNA clones in size-fractionated cDNA libraries from human brain. | 6.10e-05 | 56 | 47 | 3 | 9455484 | |
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 25134534 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 33773096 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 35210568 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 8.25e-05 | 330 | 47 | 5 | 33301849 | |
| Pubmed | 9.50e-05 | 340 | 47 | 5 | 24332808 | ||
| Pubmed | Cloning of the genes encoding two murine and human cochlear unconventional type I myosins. | 9.75e-05 | 11 | 47 | 2 | 9119401 | |
| Pubmed | Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis. | 9.75e-05 | 11 | 47 | 2 | 33849069 | |
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 9.75e-05 | 11 | 47 | 2 | 39256359 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.04e-04 | 180 | 47 | 4 | 30110629 | |
| Pubmed | 1.11e-04 | 183 | 47 | 4 | 36129980 | ||
| Pubmed | 1.15e-04 | 1440 | 47 | 9 | 30833792 | ||
| Pubmed | 1.56e-04 | 378 | 47 | 5 | 34315543 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.58e-04 | 605 | 47 | 6 | 28977666 | |
| Pubmed | 1.61e-04 | 14 | 47 | 2 | 20403135 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 1.61e-04 | 14 | 47 | 2 | 36289231 | |
| Pubmed | 1.61e-04 | 14 | 47 | 2 | 12563287 | ||
| Pubmed | GATA-1 forms distinct activating and repressive complexes in erythroid cells. | 1.61e-04 | 14 | 47 | 2 | 15920471 | |
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 1.86e-04 | 15 | 47 | 2 | 35695185 | |
| Pubmed | The chromatin remodeling factor CHD5 is a transcriptional repressor of WEE1. | 1.86e-04 | 15 | 47 | 2 | 25247294 | |
| Pubmed | 2.04e-04 | 634 | 47 | 6 | 34591612 | ||
| Pubmed | 2.40e-04 | 17 | 47 | 2 | 21257963 | ||
| Pubmed | 2.40e-04 | 17 | 47 | 2 | 27806305 | ||
| Pubmed | 2.70e-04 | 18 | 47 | 2 | 16217013 | ||
| Pubmed | LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. | 2.70e-04 | 18 | 47 | 2 | 19497860 | |
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 2.70e-04 | 18 | 47 | 2 | 28068325 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 3.10e-04 | 1294 | 47 | 8 | 30804502 | |
| Pubmed | Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. | 3.51e-04 | 101 | 47 | 3 | 19167051 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.57e-04 | 704 | 47 | 6 | 29955894 | |
| Pubmed | 3.72e-04 | 103 | 47 | 3 | 32744500 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 4.18e-04 | 1353 | 47 | 8 | 29467282 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.94e-04 | 271 | 47 | 4 | 32433965 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 5.31e-04 | 759 | 47 | 6 | 35915203 | |
| Pubmed | 5.46e-04 | 497 | 47 | 5 | 23414517 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 5.62e-04 | 1415 | 47 | 8 | 28515276 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 5.87e-04 | 1082 | 47 | 7 | 38697112 | |
| Pubmed | 7.09e-04 | 29 | 47 | 2 | 36800290 | ||
| Pubmed | Large-scale analysis of the human ubiquitin-related proteome. | 8.46e-04 | 313 | 47 | 4 | 16196087 | |
| Pubmed | 8.64e-04 | 32 | 47 | 2 | 38060382 | ||
| Pubmed | 9.40e-04 | 847 | 47 | 6 | 35850772 | ||
| Pubmed | 9.40e-04 | 322 | 47 | 4 | 26514267 | ||
| Pubmed | 9.84e-04 | 326 | 47 | 4 | 17015433 | ||
| Pubmed | Identification of the BRD1 interaction network and its impact on mental disorder risk. | 1.03e-03 | 35 | 47 | 2 | 27142060 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 1.05e-03 | 147 | 47 | 3 | 28977470 | |
| Pubmed | 1.05e-03 | 147 | 47 | 3 | 16959763 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.11e-03 | 150 | 47 | 3 | 28242625 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.12e-03 | 583 | 47 | 5 | 29844126 | |
| Pubmed | 1.16e-03 | 37 | 47 | 2 | 24335282 | ||
| Pubmed | 1.16e-03 | 37 | 47 | 2 | 23180766 | ||
| Pubmed | 1.19e-03 | 591 | 47 | 5 | 15231748 | ||
| Pubmed | A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis. | 1.22e-03 | 38 | 47 | 2 | 38346162 | |
| Pubmed | 1.22e-03 | 38 | 47 | 2 | 33283408 | ||
| Pubmed | 1.24e-03 | 156 | 47 | 3 | 37108203 | ||
| Pubmed | 1.26e-03 | 157 | 47 | 3 | 30186101 | ||
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 1.28e-03 | 39 | 47 | 2 | 19010793 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.35e-03 | 40 | 47 | 2 | 34585037 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q31 | 2.48e-05 | 164 | 47 | 4 | chr4q31 | |
| Cytoband | 4q31.3 | 4.68e-04 | 31 | 47 | 2 | 4q31.3 | |
| Cytoband | 12q24.11 | 5.31e-04 | 33 | 47 | 2 | 12q24.11 | |
| Cytoband | 19q13.43 | 3.63e-03 | 87 | 47 | 2 | 19q13.43 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.74e-04 | 12 | 30 | 2 | 1305 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 7.80e-04 | 25 | 30 | 2 | 994 | |
| GeneFamily | NLR family | 7.80e-04 | 25 | 30 | 2 | 666 | |
| GeneFamily | AAA ATPases | 3.48e-03 | 53 | 30 | 2 | 413 | |
| GeneFamily | WD repeat domain containing | 9.15e-03 | 262 | 30 | 3 | 362 | |
| GeneFamily | PHD finger proteins | 9.74e-03 | 90 | 30 | 2 | 88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-06 | 173 | 47 | 5 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-06 | 174 | 47 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-06 | 177 | 47 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-06 | 180 | 47 | 5 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-06 | 181 | 47 | 5 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-06 | 182 | 47 | 5 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-06 | 182 | 47 | 5 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.83e-06 | 127 | 47 | 4 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.95e-05 | 168 | 47 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 174 | 47 | 4 | 43c0e758fa8683708475aec846929ac70d41d7f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 174 | 47 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.54e-05 | 176 | 47 | 4 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-05 | 176 | 47 | 4 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.54e-05 | 176 | 47 | 4 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-05 | 177 | 47 | 4 | f63b62bb2be737f2d26be16943487ec27bf3bcd4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-05 | 180 | 47 | 4 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 182 | 47 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 182 | 47 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 184 | 47 | 4 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-05 | 185 | 47 | 4 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-05 | 190 | 47 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(II)|GI_large-bowel / Manually curated celltypes from each tissue | 4.77e-05 | 190 | 47 | 4 | fee64bacbb330d04dc1dc63909838f2c605d9f1f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-05 | 192 | 47 | 4 | ab7420aeb22620d85c60b33cf372e5168e538cd4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.07e-05 | 193 | 47 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.17e-05 | 194 | 47 | 4 | cbc4b6422777117e4123804168c23f19d1b79486 | |
| ToppCell | severe-B_intermediate|severe / disease stage, cell group and cell class | 5.38e-05 | 196 | 47 | 4 | 8f59e51ca50bef4753f67cd1efdb02665805a120 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.49e-05 | 197 | 47 | 4 | 9bc5fbc59c600eba2a76a801091b69270bd7d161 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.71e-05 | 199 | 47 | 4 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.91e-04 | 106 | 47 | 3 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.91e-04 | 106 | 47 | 3 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.91e-04 | 106 | 47 | 3 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 145 | 47 | 3 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | Healthy-B_cell|World / disease group, cell group and cell class | 4.89e-04 | 146 | 47 | 3 | 588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-04 | 148 | 47 | 3 | 6ffa212f0cc44c40d2143816dc6cfd82fbf09a33 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-04 | 150 | 47 | 3 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-04 | 156 | 47 | 3 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.27e-04 | 159 | 47 | 3 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-04 | 159 | 47 | 3 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-04 | 159 | 47 | 3 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.38e-04 | 160 | 47 | 3 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-04 | 161 | 47 | 3 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 163 | 47 | 3 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 163 | 47 | 3 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.48e-04 | 169 | 47 | 3 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.61e-04 | 170 | 47 | 3 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | Control-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.74e-04 | 171 | 47 | 3 | d18855b24aadea38fd1e4592f945cf15b85e05f1 | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.74e-04 | 171 | 47 | 3 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.87e-04 | 172 | 47 | 3 | 1cfea985c5959b38beea351b892cd5e92e27f927 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.87e-04 | 172 | 47 | 3 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.00e-04 | 173 | 47 | 3 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 8.00e-04 | 173 | 47 | 3 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | severe-B_memory|severe / disease stage, cell group and cell class | 8.00e-04 | 173 | 47 | 3 | 3a987ac53a0136cc4c70ce8b901a15fc00c795e1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.13e-04 | 174 | 47 | 3 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-04 | 175 | 47 | 3 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-04 | 175 | 47 | 3 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-04 | 176 | 47 | 3 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 8.41e-04 | 176 | 47 | 3 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 8.41e-04 | 176 | 47 | 3 | 5788dd5b23ebb52f19d3b5bdbcfe25dee349cf77 | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class | 8.55e-04 | 177 | 47 | 3 | 3ff06100deee9bee852a52078666999a9f7beaf1 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 177 | 47 | 3 | 0d1c39e99144fdb9c7f6f98a1ade41c73db45b65 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-04 | 177 | 47 | 3 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-04 | 177 | 47 | 3 | b5c20c1247f11ebc97e9cb47482564cd74e36ca6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 177 | 47 | 3 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-04 | 177 | 47 | 3 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-04 | 178 | 47 | 3 | da1695a936dbe3ca9ee3fb28ceb60511c47b35f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.69e-04 | 178 | 47 | 3 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.69e-04 | 178 | 47 | 3 | 580fc1d45b82010c665a313b2e7a21e0116819ef | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.83e-04 | 179 | 47 | 3 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.97e-04 | 180 | 47 | 3 | a499548391e6833b78f6e920f8e32a755814a9da | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | 87fb1fdbc49c808bb5f6fe9fb747057b45fa78d0 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.12e-04 | 181 | 47 | 3 | c1203787cc3f968147fabdd3c646a04be96f6552 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.12e-04 | 181 | 47 | 3 | f7258af89f4cc89446ff6754bdaa769320af95d6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_LZ|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.41e-04 | 183 | 47 | 3 | 30db83f600e2c4ad3af68a8a946673f4352a2807 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-04 | 183 | 47 | 3 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 183 | 47 | 3 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B-Memory_B_cells|blood / Manually curated celltypes from each tissue | 9.41e-04 | 183 | 47 | 3 | e3a418b745d7f040adf47be9e1043b945cae47ed | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.41e-04 | 183 | 47 | 3 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Memory_B_cells|bone_marrow / Manually curated celltypes from each tissue | 9.56e-04 | 184 | 47 | 3 | ffc9eec123de34a4f17ed27fe4f0a1b3cb84697f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.56e-04 | 184 | 47 | 3 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-04 | 184 | 47 | 3 | b12fb85a064f715a4f0ada1df8e422c359b573cf | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.56e-04 | 184 | 47 | 3 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-04 | 185 | 47 | 3 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.86e-04 | 186 | 47 | 3 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.86e-04 | 186 | 47 | 3 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 9.86e-04 | 186 | 47 | 3 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | Control-Lymphocyte-B-B_intermediate|Control / Disease, Lineage and Cell Type | 1.00e-03 | 187 | 47 | 3 | 90c9b1a51539838323325f563be4adf5fdf1b38f | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.00e-03 | 187 | 47 | 3 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.02e-03 | 188 | 47 | 3 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.02e-03 | 188 | 47 | 3 | ee1bb0700ab70e03a63982446a33976b9200ddb6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-03 | 188 | 47 | 3 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-03 | 188 | 47 | 3 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-03 | 189 | 47 | 3 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | ASK454-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.03e-03 | 189 | 47 | 3 | 316c857dec9383823e09f966bca62d52d933b141 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.03e-03 | 189 | 47 | 3 | 864f666b1e8557a689320075036920e3ac589b8b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-03 | 189 | 47 | 3 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-03 | 189 | 47 | 3 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| Disease | hepatocyte growth factor receptor measurement | 4.75e-05 | 7 | 45 | 2 | EFO_0008153 | |
| Disease | Colorectal Carcinoma | 8.66e-05 | 702 | 45 | 7 | C0009402 | |
| Disease | intercellular adhesion molecule 5 measurement | 1.76e-04 | 13 | 45 | 2 | EFO_0008164 | |
| Disease | QRS-T angle | 5.73e-04 | 106 | 45 | 3 | EFO_0020097 | |
| Disease | colorectal cancer (is_implicated_in) | 8.42e-04 | 121 | 45 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 9.68e-04 | 127 | 45 | 3 | EFO_0008595, EFO_0020947 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.00e-03 | 291 | 45 | 4 | EFO_0008317, EFO_0020946 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.14e-03 | 301 | 45 | 4 | DOID:684 (is_marker_for) | |
| Disease | mean reticulocyte volume | 1.28e-03 | 799 | 45 | 6 | EFO_0010701 | |
| Disease | malignant epithelial tumor of ovary | 1.31e-03 | 35 | 45 | 2 | MONDO_0018364 | |
| Disease | mean corpuscular hemoglobin concentration | 1.32e-03 | 1105 | 45 | 7 | EFO_0004528 | |
| Disease | duodenal ulcer | 1.39e-03 | 36 | 45 | 2 | EFO_0004607 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.46e-03 | 37 | 45 | 2 | EFO_0022281 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMWKMGIRNSFTMEA | 521 | Q8NEM8 | |
| WQDVSMRRMEMISDF | 181 | P16442 | |
| MSKMMTVLGAKWREF | 181 | Q8TDI0 | |
| FVLFRSSMNWMMSMH | 211 | Q3ZCU0 | |
| FWVMFKMDASLTDTM | 136 | O95267 | |
| NLMKMMGLQDSAFWL | 251 | Q8N139 | |
| LMQRMSDMLSRWFEE | 341 | Q58WW2 | |
| MWKMMLNIDVSATAF | 211 | Q9H9G7 | |
| SMDRKWRGKMVFSMN | 81 | Q5W186 | |
| TMSEMKMGRYWSKEE | 931 | Q6ZMN7 | |
| DQMFWEVMQLRKEMS | 451 | Q96QF0 | |
| RTQKFKAMLWMCEEF | 356 | Q8IZ07 | |
| FMFDDMMRIKTWHFS | 186 | Q86U70 | |
| WNMLFSIFSMMRKED | 66 | P59045 | |
| WMMFSEITFQSDAAM | 356 | Q16832 | |
| RLRMWTDTEFENMDM | 216 | Q9ULI0 | |
| MTMFKGSNEMKSRWN | 1 | B0L3A2 | |
| SEMWDKMKDFQDLML | 336 | Q8IVH4 | |
| MRFSMDFWQKMLALG | 366 | O75530 | |
| MKLMMAWSDNKIFRD | 166 | Q96MN2 | |
| MRWMNHKKSRVMDFF | 7036 | Q9UPN3 | |
| AFKAMLRQDMSWFDD | 791 | P21439 | |
| EEEMSWKDMFAFMGS | 256 | Q9NWV8 | |
| MLRKEMEMLWNKTFE | 106 | A0A1B0GTZ2 | |
| MLMIFMIWEAFASKR | 466 | P00395 | |
| MMMVLGAKWREFSTN | 201 | Q14839 | |
| MQDKFNFMMLWASQG | 271 | Q9UNU6 | |
| EFMKWKEAMFSAGMQ | 451 | Q92541 | |
| FKQTWMNNMMKTSEA | 211 | Q02880 | |
| DSMVMRWDGSMFRLL | 431 | Q8N135 | |
| NMDLLWMAEAKMPRF | 236 | Q9BXW7 | |
| WNMNEKLMTPEMFSE | 206 | Q12824 | |
| AWMSEQELYMMSEEK | 1606 | Q01082 | |
| FFSMVRDLMLWMEDV | 1916 | Q01082 | |
| HEATAMMKAQFMSLW | 206 | Q8NBU5 | |
| MMKAQFMSLWDGLDT | 211 | Q8NBU5 | |
| WSFMLRIPEKKNMMS | 276 | Q9Y6Q2 | |
| FFDMHMMVSKPEQWV | 66 | Q2QD12 | |
| IAKLWDSKMFAEIMM | 51 | Q8WWY3 | |
| RMAWMTSDVFEQWMR | 256 | Q8IY51 | |
| SKMMWCSAAVDIMFL | 41 | Q5GFL6 | |
| FMDSKMKPLWIMYSN | 751 | O00329 | |
| WTILRDDFMMGASMK | 246 | Q9Y3B9 | |
| YVFVSSWMMKMESIL | 406 | Q2M389 | |
| MEELDKWMNSMNRNA | 146 | Q6P9G4 | |
| RKWMEQFEMAMSNIK | 501 | P52735 | |
| SQFFSASRDRMVMMW | 116 | Q8NA23 | |
| FFDMHMMVSKPEQWV | 66 | Q96AT9 | |
| QFMMTNKLDTAMWLS | 16 | P57088 | |
| WDMTRMLNMLIVFRF | 541 | Q8NHX9 |